Ocugen and Assertio are slated to join the Russell Microcap Index following a preliminary roster release on Monday [1, 2].
Index reconstitutions are significant because they often trigger automatic buying and selling by institutional funds that track these benchmarks. The addition of a company can increase its visibility to investors and potentially drive up trading volume.
FTSE Russell said it is conducting these changes as part of its semi-annual index reconstitution [1, 2]. This process rotates constituents to reflect current market changes and ensure the index accurately represents the microcap equity landscape. While Ocugen and Assertio are slated for entry, other healthcare firms will leave the index [1, 2].
Definium Therapeutics and Tvardi Therapeutics are slated to be removed from the Russell Microcap Index [1]. The removal of a company can lead to a decrease in institutional ownership as index-tracking funds divest their positions to maintain the index's weighting requirements.
There are conflicting reports regarding the specific indices involved in this shuffle. One report said that Ocugen and Assertio are joining the Russell Microcap Index [1]. Another report said that Ocugen and Nektar are instead slated to join the Russell 3000 Index [2].
Both reports agree that the changes are part of the broader semi-annual update conducted by FTSE Russell to maintain the integrity of its market benchmarks [1, 2].
“Ocugen and Assertio are slated to join the Russell Microcap Index”
The semi-annual reconstitution of Russell indices creates a period of forced volatility for the affected stocks. When a company is added to a major index, passive funds must purchase shares to match the index, often creating upward price pressure. Conversely, companies being removed typically face selling pressure. The discrepancy in reports regarding the Russell 3000 versus the Microcap index suggests that some healthcare firms may be moving between different tiers of the Russell family of indices based on their current market capitalization.
